Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-29 Sale | 2024-03-04 7:40 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 22,466 | $1.1782 | $26,470 | 329,511 (Direct) | View |
| 2024-02-15 Sale | 2024-02-20 4:59 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 5,847 | $1.3312 | $7,783 | 163,772 (Direct) | View |
| 2023-07-28 Sale | 2023-08-01 5:37 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 2,845 | $1.7 | $4,837 | 156,286 (Direct) | View |
| 2023-02-15 Sale | 2023-02-17 4:07 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 5,869 | $3.1891 | $18,717 | 64,131 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-28 Option Award | 2024-02-29 5:35 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 188,205 | $0 | 351,977 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-25 7:14 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 13,333 | $0 | 169,619 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 5:38 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 95,000 | $0 | 159,131 (Direct) | View |
Ownership | 2022-08-19 4:15 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 0 | $0 | 180,000 (Direct) | View |